Back to Search

GUIDO TRICOT, MD

MD

Hematology & Oncology Physician

NPI: 1063502540Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

6630705(UT)SP210(IA)
Internal Medicine Physician

Internal Medicine

Code: 207R00000X

SP210(IA)
Medical Oncology Physician

Internal Medicine — Medical Oncology

Code: 207RX0202X

SP210(IA)

Research & Publications (20)

Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization.
PMID 19543330·Bone Marrow Transplant·2010
3-trial
RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.
PMID 19458357·Blood·2009
7-preclinical
Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).
PMID 19423744·Blood·2009
3-trial
Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
PMID 19535776·J Natl Cancer Inst·2009
8-other
Bleeding disorders associated with cancer dysproteinemias.
PMID 19377931·Cancer Treat Res·2009
6-review
Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
PMID 19367157·Blood Coagul Fibrinolysis·2009
8-other
Network dynamics and species exchange processes in aluminophosphate glasses: an in situ high temperature magic angle spinning NMR view.
PMID 19093834·J Phys Chem B·2009
8-other
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2.
PMID 18302711·Br J Haematol·2008
2-rct
Response to bortezomib in refractory type I cryoglobulinemia.
PMID 18756542·Am J Hematol·2008
5-case
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma.
PMID 17947507·Blood·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
200 HAWKINS DR
IOWA CITY, IA 52242

Quick Facts

NPI
1063502540
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
4
Locations
1
Publications
20

Are you this provider?

Claim Your Profile